CC
AXDX

Chicago Capital’s Accelerate Diagnostics AXDX Stock Holding History

Chicago Capital’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,000
Closed -$30K – 228
2022
Q3 		$30K Hold
2,000
– – ﹤0.01% 232
2022
Q2 		$20K Sell
2,000
-8
-0.4% -$71 ﹤0.01% 237
2022
Q1 		$29K Buy
2,008
+8
+0.4% +$228 ﹤0.01% 252
2021
Q4 		$104K Sell
2,000
-56,379
-97% -$3.14M ﹤0.01% 259
2021
Q3 		$3.4M Sell
58,379
-92,175
-61% -$6.01M 0.13% 68
2021
Q2 		$12.1M Sell
150,554
-8,759
-5% -$696K 0.47% 46
2021
Q1 		$13.3M Sell
159,313
-1,511
-0.9% -$153K 0.56% 46
2020
Q4 		$12.2M Sell
160,824
-35,865
-18% -$3.21M 0.54% 46
2020
Q3 		$21M Buy
196,689
+121,141
+160% +$16.8M 1.08% 37
2020
Q2 		$11.5M Sell
75,548
-14,228
-16% -$1.4M 0.66% 42
2020
Q1 		$7.48M Sell
89,776
-41,633
-32% -$5.86M 0.6% 47
2019
Q4 		$22.2M Buy
131,409
+43,270
+49% +$7.14M 1.36% 37
2019
Q3 		$16.4M Buy
88,139
+33,511
+61% +$6.48M 1.1% 41
2019
Q2 		$12.5M Buy
54,628
+5,246
+11% +$1.03M 0.8% 47
2019
Q1 		$10.4M Buy
49,382
+6,963
+16% +$1.31M 0.71% 51
2018
Q4 		$4.88M Sell
42,419
-20,586
-33% -$3.05M 0.4% 55
2018
Q3 		$14.5M Buy
63,005
+9,186
+17% +$2.03M 1% 42
2018
Q2 		$12M Buy
53,819
+24,965
+87% +$5.58M 0.97% 45
2018
Q1 		$6.59M Buy
+28,854
New +$7.58M 0.88% 43

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Chicago Capital's AXDX Position: Q4 2022 in Review

Chicago Capital sold out of Accelerate Diagnostics (AXDX) in Q4 2022, closing a stake of 2,000 shares — an estimated $30K sold.

Chicago Capital first reported a position in AXDX in Q1 2018 and held it in 19 quarters. The position peaked at $22.2M in Q4 2019. 72 funds tracked by Wall St. Rank hold AXDX as of Q4 2022.

  • Chicago Capital reported no remaining Accelerate Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Chicago Capital sold 2,000 Accelerate Diagnostics shares in Q4 2022, an estimated $30K.
  • Chicago Capital first reported a position in Accelerate Diagnostics in Q1 2018 and held it in 19 quarters.
  • Chicago Capital's Accelerate Diagnostics position peaked at $22.2M in Q4 2019.
  • 72 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2022.

Based on Chicago Capital's 13F filing for Q4 2022, filed 20 Jan 2023.